爱美之心人皆有之，爱美是人的天性。生活中，很多人都有佩戴饰品的习惯——可是这些饰品一旦带入 手术室，就有可能影响手术安全。 通常，手术室护士在对病人进行术前访视时，会再三叮嘱"手术前要将手表、项链等饰品摘掉；如果做 了美甲或涂了指甲油，也要及时处理掉；隐形眼镜和假牙也不可以带入手术室"……相信大部分患者都 会配合，但同时也可能会感到疑惑。本文将为大家介绍哪些物品不能被带入手术室，并解释原因。 一、首饰为什么不能带入手术室？ 1、携带病菌 手术室是一个需要保持高度无菌的地方，而首饰由于长时间的暴露在空气中，首饰的表面附着着大量的 细菌、病毒等病原体，如果将其带入手术室，可能会增加感染的风险。 2、皮肤受压 在一些手术需要摆放特殊体位时，如果刚好在佩戴首饰的部位，长时间受压可能导致局部皮肤血供变 差，容易造成皮肤的压力性损伤。 3、有误伤的风险 手术室有许多电外科设备，比如我们手术时所用的电刀等设备，它是利用电流的原理进行切割和止血 的，如果佩戴耳环、手镯等金属这一类首饰，它就起到了导电的作用，可能会增加电灼伤的风险。所以 为了自身安全，请不要将首饰带入手术室。 4、手术需要 有些首饰会影响手术视野和穿刺部位的暴 ...

Group 1 - The short drama production team Shanghai Tinghua Island Cultural Media Co., Ltd. donated 1 million yuan to Beijing SmileAngel Children's Hospital for daily operations and medical support for children with cleft lip and palate in impoverished areas [1][7] - The donation reflects ongoing concern for the difficulties faced by children with cleft lip and palate and recognition of the charitable achievements of SmileAngel Children's Hospital [7] - Shanghai Tinghua Island is a well-known short drama production team, with representative works including "Eighteen-Year-Old Great-Grandma Arrives," "I Am a Stepmother in the 1980s," and "Family Inside and Outside" [7] Group 2 - The company emphasized the importance of ensuring that the donated funds are used effectively for the children who need help the most, indicating a commitment to monitoring the use of the funds [7] - A certificate of appreciation was awarded to the company in recognition of its commitment to helping children with cleft lip and palate [4]

烟台山医院党委委员、副院长孙涛详细介绍了医院的发展历程、学科建设与临床资源优势，全面展现了 医院作为区域医疗中心的综合实力。 扬子江药业集团山东鲁圣战术部负责人李淑敏围绕企业区域布局、核心优势作了介绍；山东鲁圣战术部 医学负责人仇荟然深度解析了战略合作的核心项目与实践路径，明确双方将在药物研发、临床试验、学 科共建、人才联合培养等领域展开全方位合作。 随后，双方共同签署战略合作协议，秉持"优势互补、共同发展"原则，在医药健康领域深耕细作，打造 院企协同创新标杆，共同推动区域医疗健康事业高质量发展。 齐鲁晚报·齐鲁壹点 孙淑玉 通讯员 潘峰 近日，烟台市烟台山医院与扬子江药业集团有限公司举行战略合作签约仪式，标志着双方正式开启优势 互补、资源整合的深度协同新篇章。 烟台市烟台山医院党委书记、院长姜俊杰在致辞中表示，医院始终秉持"开放共赢、互学互鉴"理念，始 终以"以患者为中心"的初心守护群众健康。扬子江药业作为全国首批创新型企业，践行"高质、惠民、 创新、至善"的核心价值观，以"三药并举"战略筑牢创新根基。双方发展理念高度契合，此次合作既是 响应国家"健康中国"战略的具体实践，更彰显了携手服务民生、共促行业发展 ...

1月21日的资金流向数据方面，主力资金净流入3845.08万元，占总成交额3.3%，游资资金净流入 4050.81万元，占总成交额3.48%，散户资金净流出7895.88万元，占总成交额6.78%。 | | | | | 日期 收盘价 涨跌幅 主力净流入 主力净占比 游资净点比 散户净流入 散户净占比 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 2026-01-21 | 28.37 | -0.14% | 3845.08万 | 3.30% | 4050.81万 | 3.48% | -7895.88万 | -6.78% | | 2026-01-20 | 28.41 | -3.20% | -9828.11万 | -7.33% | -4303.63万 | -3.21% | 1.41亿 | 10.54% | | 2026-01-19 | 29.35 | 0.51% | -9841.20万 | -6.09% | -2407.44万 | -1.49% | 1.22亿 | 7.58% | | 2026-01-16 | 29.20 | - ...

Core Insights - OpenAI and Anthropic have launched health features for general users and products for the healthcare industry, marking their entry into the healthcare sector [1] - ChatGPT has over 800 million users, with 25% submitting health-related queries weekly, and over 40 million daily consultations on health issues [1][7] - The Chinese government has released guidelines to promote AI in healthcare, leading to the emergence of AI health assistants [1][15] Group 1: Global Trends in Conversational AI Health Assistants - Conversational AI health assistants are becoming a new highlight in the domestic AI + healthcare landscape [2][3] - International users prefer general AI assistants for medical consultations, while specialized AI assistants are helping reduce the workload of doctors in Europe and the US [2][5][9] Group 2: Driving Factors and Challenges - Changes in interaction habits and advancements in AI capabilities are driving a new wave of healthcare service upgrades [15][16] - The competition in AI applications is intensifying, with healthcare being viewed as a new growth area [15][18] - Despite the promising outlook, conversational AI health assistants face numerous challenges [21] Group 3: Development Strategies for AI Health Assistants - There is a need to enhance data openness and innovation support to drive industry innovation through AI health assistants [27] - Industry self-regulation is essential, along with increased safety measures for AI health assistants [30][31] Group 4: Future Prospects - The potential for conversational AI health assistants to become a new entry point for traffic is increasing [33] - The demand for health management is rising, especially among the aging population and health-conscious younger generations [35][36] Group 5: Market Dynamics and Business Models - The pressure for commercial monetization is leading to strategic choices, with the healthcare market seen as a significant opportunity [19][23] - Various potential business models for AI health assistants are still in early exploration stages [23] Group 6: Regulatory and Ethical Considerations - The regulatory framework for AI health assistants is still unclear, necessitating adjustments to promote development [24] - There is a call for industry self-discipline to ensure sustainable AI transformation in healthcare [31][32]

12月31日,患者赵老先生,因突发剧烈腹痛、高热伴全身黄染在当地医院就诊,脾胃病科王燕主任带领内镜 团队第一时间接诊,迅速组织紧急会诊。结合患者危重病情与高龄特点,团队决定施行急诊联合子镜直视 下液电碎石取石术。 近日,荣成市中医院脾胃病科团队勇闯"高龄禁区",为一位87岁患者成功实施急诊内镜下逆行胰胆管造影 联合子镜直视下液电碎石取石术,精准破解胆总管巨大结石嵌顿的生命危机。 在麻醉科的全力护航下,整个手术历时1小时,过程顺利,未发生出血、穿孔等任何并发症。术后,赵老先生 的腹痛即刻得到明显改善,体温快速恢复正常,周身黄染也逐渐消退。此次为87岁患者的成功救治,是科室 在高龄高危胆道急症临床诊疗中的一次积极实践。未来,脾胃病科将持续精进精准微创技术,以优质诊疗 服务,为更多异地疑难胆胰疾病患者保驾护航。(董昊) ...

股票代码：000700 股票简称：模塑科技 投资者关系活动类别 √特定对象调研 □分析师会议 □媒体采访 □业绩说明会 □新闻发布会 □路演活动 □现场参观 □其他 活动参与人员 东北证券（2 位）、华西证券、天演论投资（2 位） 上市公司接待人员 董事会秘书：单琛雁 证券事务代表：王晖 证券专员：陆锴 时间 2026.1.19—2026.1.21 形式 线下 交流内容及具体问答 记录 公司与投资者就以下问题进行了交流 1、请公司介绍下主营业务情况。 答：公司是中国领先的汽车外饰件系统服务供应商，主营业务聚焦于 汽车保险杠等汽车外饰系统零部件的研发、生产和销售。 公司年汽车保险杠生产能力达 600 万套以上，在无锡、上海、沈阳、 武汉、烟台、墨西哥设有生产基地，在北京、上海及江阴设有研发中心。 参股公司北汽模塑在北京、合肥、重庆、成都、株洲设立生产基地。 2、公司主要客户有哪些？ 答：公司核心客户覆盖全球豪华品牌与新能源车企，主要客户包括宝 马、北京奔驰、上汽通用、吉利、北美知名电动车企、理想、赛力斯、国 内新锐电动车企、蔚来、小鹏等。 3、公司 2025、2026 年毛利率趋势？ 答：毛利率受原材料价格变动 ...

Market Overview - The medical services sector increased by 0.18% on January 21, with Nanmo Biology leading the gains [1] - The Shanghai Composite Index closed at 4116.94, up 0.08%, while the Shenzhen Component Index closed at 14255.12, up 0.7% [1] Top Gainers in Medical Services - Nanmo Biology (688265) closed at 49.79, up 7.01% with a trading volume of 20,000 shares and a transaction value of 98.02 million [1] - Hite Biology (300683) closed at 29.67, up 5.74% with a trading volume of 107,800 shares and a transaction value of 32.2 million [1] - Dean Diagnostics (300244) closed at 26.46, up 5.59% with a trading volume of 796,300 shares and a transaction value of 2.13 billion [1] - ST Zhongzhu (600568) closed at 2.64, up 5.18% with a trading volume of 376,500 shares and a transaction value of 9.81 million [1] - Tongce Medical (600763) closed at 46.51, up 4.99% with a trading volume of 198,600 shares and a transaction value of 911 million [1] Top Losers in Medical Services - Digital Human (920670) closed at 18.72, down 4.44% with a trading volume of 74,500 shares and a transaction value of 143 million [2] - Hongbo Pharmaceutical (301230) closed at 46.36, down 1.88% with a trading volume of 131,200 shares and a transaction value of 614 million [2] - Chengda Pharmaceutical (301201) closed at 41.39, down 1.76% with a trading volume of 36,600 shares and a transaction value of 153 million [2] Capital Flow in Medical Services - The medical services sector saw a net inflow of 50.51 million from institutional investors, while retail investors experienced a net outflow of 375 million [2] - The sector's overall capital flow indicates a strong interest from institutional and speculative investors, with retail investors pulling back [2][3] Notable Capital Inflows - Sanbo Brain Science (301293) had a net inflow of 91.48 million, representing 9.03% of its total capital [3] - Tongce Medical (600763) saw a net inflow of 83.46 million, accounting for 9.16% of its total capital [3] - BGI Genomics (300676) recorded a net inflow of 51.81 million, which is 8.37% of its total capital [3]

Group 1 - The core viewpoint of the article highlights the positive signals from the JPM conference, reinforcing the industrial positioning of AI in healthcare [1] - In early 2026, multiple AI pharmaceutical collaborations have been established globally, with over 9 partnerships among multinational pharmaceutical companies, totaling more than $6 billion [1] - AI in pharmaceuticals enhances the entire drug development process, improving efficiency and success rates in new drug discovery, preclinical screening, clinical development, and production, indicating a future high-growth trajectory [1] Group 2 - Continuous attention should be paid to investment directions in AI healthcare, including AI health management, AI medical information technology, AI medical imaging, AI surgical robots, AI gene sequencing, and AI pharmaceuticals [1] - The competitiveness of Chinese innovative pharmaceuticals is highlighted, with Chinese companies actively engaging in business development overseas in areas such as bispecific antibodies, ADCs, and GLP-1RA new drugs by 2025 [1] - The medical ETF (159828) tracks the CSI Medical Index (399989), which selects listed companies in the A-share market involved in medical devices, medical services, and medical information technology, reflecting the overall performance of healthcare-themed listed companies [1]

Core Viewpoint - The article highlights the significant advancements in healthcare services in Sichuan Province, emphasizing the integration of technology, community health initiatives, and targeted policies to improve public health outcomes and accessibility [5][15]. Group 1: Healthcare Achievements - Sichuan Province has seen an increase in life expectancy to 78.8 years, with maternal and infant mortality rates consistently below the national average for 9 and 18 years respectively [5][15]. - The province has established 65 provincial quality control centers and 1190 municipal centers, leading the nation in the application of electronic medical record systems [5]. - By 2025, Sichuan aims to provide 387,000 childcare positions, addressing the challenges of parenting [10]. Group 2: Technological Integration - The province has implemented smart healthcare solutions, such as AI systems that assist in patient follow-ups and data analysis, significantly reducing the time required for healthcare professionals to manage patient information [6][7]. - AI services from companies like Huawei and Baidu have been integrated into 258 grassroots healthcare institutions, providing assistance to over 20 million patients [7]. - The "Internet + Nursing Services" initiative has led to the establishment of 313 smart hospitals and 496 internet hospitals, enhancing service delivery [8]. Group 3: Community Health Initiatives - Sichuan has focused on vulnerable populations, including the elderly and children, with policies aimed at reducing the financial burden of childcare and healthcare [9][10]. - The "Health Door Knocking Action" has provided free services to over 2.68 million disabled elderly individuals, showcasing the province's commitment to elderly care [10][12]. - The "Panda Health Train" initiative has brought mobile healthcare services to remote areas, improving access to medical care [11][12]. Group 4: Collaborative Healthcare Network - The province has developed a comprehensive healthcare network that facilitates efficient patient referrals and resource sharing among hospitals [13][14]. - Sichuan has established 39 tight-knit urban medical groups and 192 county-level medical communities, enhancing collaboration between urban and rural healthcare services [14]. - The integration of healthcare, insurance, and pharmaceuticals has been prioritized, with a focus on collaborative governance to improve overall health outcomes [15][19].